There will be many specialists from different countries giving interesting lectures and carrying out the postgraduate courses at the 49th Nordic Lung Congress. Below you will find their short introductions. This website is continuously updated whenever more lecturers register. In total we are expecting around 100 lecturers!

ALAN ALTRAJA, the Congress Chair, is a Professor of Pulmonary Medicine and the Head of the Department of Pulmonology at the University of Tartu, Estonia. He graduated from the Faculty of Medicine, University of Tartu in 1990, trained at the Helsinki University Hospital, Finland, and specialized in pulmonary medicine at the University of Tartu in 1999. Alan Altraja received the scientific degree of Doctor of Medicine and Surgery (Ph.D.) from the University of Helsinki in 1999.
Prof. Altraja’s research interests include asthma and COPD with metabolomics and the systems biology-based approach; tuberculosis, and interstitial lung diseases.
Alan Altraja is a member of the Board of the Estonian Respiratory Society and a member of the European Respiratory Society, the International Union of Tuberculosis and Lung Diseases, and the Nordic Respiratory Academy. Prof. Altraja has been an Associate Editor of the Clinical Respiratory Journal/European Clinical Respiratory Journal and has contributed to numerous international journals as a reviewer.

ARE MARTIN HOLM is a pulmonologist at Oslo University Hospital, associate professor at the University of Oslo and chair of the Scandiatransplant Heart and Lung Group. His main field of interest is lung transplantation. He will give a talk about the importance of diagnosis for lung transplantation, and he will chair the session about lung transplantation.
ARNULF LANGHAMMER has  been involved in the HUNT Study, a population based study in Mid-Norway, for the last 25 years. He is the leader of the HUNT databank and project leader of the Lung Study and Osteoporosis Study. The HUNT Study has collected data in four surveys from 1984 to 2019 for the age group 12-100 years, and have comprehensive data from questionnaires, interviews, clinical measurements, as well as analyses of blood and urine. Data can be linked to most national and regional health registers.
Besides being professor at NTNU, he has worked as a specialist in General Practice for three decades.
BODIL IVARSSON is a registered nurse (1978), has a PhD in cardiothoracic surgery nursing (2005), is an associate professor in cardiothoracic surgery nursing (2012). Bodil has established and is the leader of the research environment  “Heart or lung transplantation from patients and next of kin's perspective” and "Psychosocial issues in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension". Bodil will present research projects, which includes several studies, the patient's experiences of waiting for a heart and/or lung transplantation, and their next of kin, experiences of information, support and the psychosocial issue before the transplantation and during a long period after the transplantation.
BRYNDIS HALLDORSDOTTIR has an RN,MSc from the University og Iceland, she is a Clinical Nurse Specialist at the Landspitali, University Hospital Reykajvik Island. Working from 2009 at the outpatient clinic for longterm pulmonary patients and home mechanical dependent people, from 1997-2009 working at the sleep research Unit at landspitali, from 1981-1997 Health Care Centers in  Reykjavik

CECILIE SVANES is a professor at the Centre for International Health, University of Bergen (UiB), and a consultant in pulmonary medicine at Dept Occupational Medicine, Haukeland University hospital (HUS) in Bergen, Norway. She leads the Norwegian facility for specific inhalation challenge diagnostics of occupational lung disease.  Her main research focus has been the early life origins of respiratory health and disease, and she leads the work on this topic in the ECRHS/RHINE studies. She is increasingly focusing on the study of preconception and transgenerational determinants of lung health and allergies, and has conceived and is leading the RHINESSA multi-generation multi-centre study.
In her presentation she will present new research on preconception determinants of respiratory health and disease, and thereby possibly give us a glimpse into the future of respiratory epidemiology.

Prof, Ph.D. Celeste Porsbjerg is a professor of severe asthma at the Department of Respiratory Medicine at Bispebjerg Hospital, Copenhagen, where she heads the severe asthma clinic, and co-chairs the Respiratory Research Unit. Celeste Porsbjerg is furthermore the director of the Copenhagen Center for Translational Research (CCTR). Her research revolves around solving key clinical issues in difficult asthma, understanding disease mechanisms, and personalising asthma management. Celeste Porsbjerg chairs the Danish Severe Asthma Registry (DSAR), and is the national representative for Denmark in SHARP and ISAR.
CLARA HJALMARSSON is a consultant cardiologist working at Sahlgrenska University Hospital since 2005. She is mostly working within the field of heart failure, heart transplantation and pulmonary arterial hypertension, which is also her main research focus.
The topic of her presentation is the impact of age and comorbidity on outcome in idiopathic pulmonary arterial hypertension (IPAH). Recent reports from worldwide pulmonary hypertension registries show a new demographic picture of the IPAH population. The prevalence among the elderly is increasing, with a mean age of 50 to 65 years reported at diagnosis. She will discuss the results of a recent study in which - based on data from the Swedish Pulmonary Arterial Hypertension Registry - the impact of age and comorbidities on survival was assessed.
GÖRAN RADEGRAN, Associate Professor, DMSc, MD, M Sc Eng Phys, is the Head of the Swedish Society of Pulmonary Hypertension, & the Head of the Hemodynamic Lab & PAH Ward, VO. Heart & lungmedicine, at Skåne University hospital in Lund, Sweden. Göran Rådegran works with PAH, CTEPH, heart failure and heart transplantation investigations and follow-up. At the present Conference a focus of the presentation will be on risk stratification in PAH diagnosis & follow-up.
HELGA JONSDOTTIR, Dr, RN, PhD, FAAN, is a Professor at the Faculty of Nursing, School of Health Sciences, University of Iceland and holds a joint position as an academic chair of nursing care for chronically ill adults at Landspitali University Hospital Reykjavik Iceland. She received her master’s and doctoral degree in nursing from the University of Minnesota in the USA.
The presentation will focus on two hitherto considered distinct approaches to care of people with COPD – palliative care and symptom management- and propose a merging on the form of partnership based care.
LIGA KUKSA, currently Head of the Multi-Drug-Resistant Tuberculosis (MDR-TB) Department at the Tuberculosis and Lung Disease Clinic at Riga East University Hospital, Riga, Latvia. Received MD in 1995 from the Medical Academy of Latvia, and specialized in Pulmonology in 1998. Have been involved in the World Health Organization (WHO) Collaborating Centre for Research and Training in Management of MDR-TB’s training activities since 2000, and currently is leading WHO CC.

MAGNUS SKÖLD, MD, PhD, is a Professor of Respiratory Medicine, Department of Medicine Solna, Respiratory Medicine Unit and Center for Molecular Medicine, Karolinska Institutet and Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden. Sköld graduated MD from Lund University 1983, received a PhD at Karolinska Institutet (KI) 1991. He became associate professor 1996 and full professor 2007 at KI. He is specialized in pulmonary medicine and is a senior consultant at the Karolinska University Hospital. In 1996-1998, he was a visiting research associate at the University of Nebraska Medical Center, Omaha, USA.  His research includes translational studies on chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). In particular, he has been interested in the relatively large proportion of COPD patients that have never smoked.
The plenary lecture will include an overview of COPD in neversmokers including epidemiology, possible mechanisms and clinical manifestations.

MARIAN PETERSEN, has studied since 2002 and in 2012 she obtained a doctorate in medical science from Lund University with the subjects of sleep and sexuality. She enjoys reading literature, writing protocols, creating surveys and analyzing data to finally see and disseminate results.
Both quantitative and qualitative studies are important and complementary, and the best study has been achieved with a broad research group where professionalism and competencies can complement.
Her presentation at the 49th Nordic Lung Congress will focus on sexuality, family life and some of the challenges CPAP treatment provides as well as discuss what we can promise the patient.
MARIEKE J. VAN DER WERF is the head of the Disease Programme Tuberculosis at the European Centre for Disease Prevention and Control in Stockholm where she is responsible for the scientific and technical work of the Centre on tuberculosis surveillance, diagnosis, guidance development, and country support. She was trained as a medical doctor, in biomedical sciences, and in public health and obtained her PhD in 2003. She published more than 100 articles in international peer-reviewed journals and participated in international policy and guideline development groups, such as the World Health Organization STAG-TB and the Task Force Impact Measurement.
is Professor of Epidemiology in the Department of Health Sciences at Brock University in Canada. Also, Dr. Tammemägi is Scientific Lead on Cancer Care Ontario’s Lung Cancer Screening Pilot for People at High Risk.  Tammemägi’s research has a focus on lung cancer screening, lung cancer risk prediction modeling and prediction modeling of which pulmonary nodules detected on computed tomography are cancer. Tammemägi has been a co-investigator and remains an active analyst in several major U.S. and Canadian lung cancer screening trials, including the U.S. National Lung Screening Trial.
Tammemägi will present an update to selected perspectives on lung cancer screening. 


ROGER HESSELSTRAND works as senior Consultant and associate professor at the Department of Rheumatology, Skåne University Hospital, Sweden. He is in charge of the care of patients with systemic sclerosis and leads the researchgruop on this disease. He has a particular interest in pulmonary arterial hypertension which affects many of these patients and will lecture about the disease, risk factors, screening, prognosis and treatment.
SIMEN ALEXANDER STEINDAL is RN and associate professor. His research areas are COPD, breathlessness, symptom management and living with chronic illness.  Steindal has previously worked at a hospital lung ward.

Effectiveness of nursing interventions to manage breathlessness in COPD
Even though interventions to control breathlessness take a multidisciplinary approach for patients with COPD, these interventions are often led, coordinated or delivered by nurses. A systematic review with meta-analysis was conducted to provide a broader understanding of the effectiveness of specific tasks applied by nurses and interventions that could be implemented in clinical practice. Three categories of nursing interventions were identified: interventions performed at home, in a clinic with home follow-up, or in a clinic.

TARJA SAARESRANTA, MD, PhD is a Chief Specialist at the Department of Pulmonary Diseases, Division of Medicine, Turku University Hospital in Turku, Finland and Acting Professor and director of the Sleep Research Centre at the University of Turku, Finland.  She obtained her specialist degree in pulmonary medicine in 1993 (University of Turku), PhD degree in 2000, and special competence in Sleep Medicine in 2001 (Finnish Medical Association).  Her research has focused on sleep-disordered breathing, chronic respiratory failure as well as the effect of menopause on sleep, and is participating in the ESADA network. She is an author of over 90 peer-reviewed papers and 13 book chapters.
THORBJORG SOLEY INGADOTTIR has an RN and MSc. She is a Clinical Nurse Specialist at the outpatient department for chronic lung patients at Landspitali University Hospital.
ULLA ANTTALAINEN, MD, PhD is a Specialist at the Department of Pulmonary Diseases, Division of Medicine, Turku University Hospital in Turku, Finland.  She obtained her specialist degree in 2002 and PhD degree in 2008 (supervisor Prof. Olli Polo and MD, PhD Tarja Saaresranta, University of Turku). Her research has focused on sleep-disordered breathing, the disease among women especially and co-morbidities of sleep-disordered breathing. She has particular expertise in the diagnosis and treatment of sleep-disordered breathing and chronic non-invasive ventilation. She is responsible of the HDU at the pulmonary ward and started the telemonitoring of NIV in respiratory failure patients in Turku University Hospital. She is participating in the ESADA network and the Task Force for the Finnish Current Care Guidelines of Adult Sleep Apnoea.
She will lecture about the clinical experiences of telemonitoring of NIV in respiratory failure patients.